08/29/2013
Santo Ferrarello, MD; Sandeep Basavarajaiah, MD, MRCP, MBBS; Alaide Chieffo, MD; Masanori Kawaguchi, MD; Matteo Montorfano, MD; Charbel Naim, MD; Mauro Carlino, MD; Francesco Giannini, MD; Filippo Figini, MD; Azeem Latib, MD, BCh, MBBCh; Toru Naganuma, MD; Alessandro Sticchi, MD; Antonio Colombo, MD
This study compares the long-term (2-year) clinical outcomes of everolimus-eluting (EES) and Resolute zotarolimus-eluting (R-ZES) stents in the treatment of coronary bifurcation lesions.
This study compares the long-term (2-year) clinical outcomes of everolimus-eluting (EES) and Resolute zotarolimus-eluting (R-ZES) stents in the treatment of coronary bifurcation lesions.
This study compares the...